Harlow John B. Jr.
President and COO
Harlow John B. Jr. has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including LRMR, ESPR, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Nov 12, 2026.
On the most recent filing, Harlow John B. Jr. is listed as President and COO at Larimar Therapeutics, Inc. Inside the rolling window, Harlow John B. Jr. reported 1 open-market purchase totaling $50K in LRMR and no open-market sales.
Companies traded
Other insiders at LRMR
Insider Buying
$50K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Harlow John B. Jr. made?
Harlow John B. Jr. has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including LRMR, ESPR since 2025.
Which companies does Harlow John B. Jr. trade?
Harlow John B. Jr. has filed SEC Form 4 disclosures for 2 companies, including LRMR, ESPR.
When was Harlow John B. Jr.'s most recent SEC Form 4 filing?
Harlow John B. Jr.'s most recent SEC Form 4 filing on Tracefour is dated Nov 12, 2026.
What is Harlow John B. Jr.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Harlow John B. Jr. is listed as President and COO.
What is Harlow John B. Jr.'s total buy and sell value in the current window?
Inside the rolling retention window, Harlow John B. Jr. bought $50K and sold $0 based on SEC Form 4 filings.
What was Harlow John B. Jr.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 17,800 LRMR shares on 2026-11-11, worth $50K, per SEC Form 4 filings.